LeapFinancial | $3,500,000 | (Dec 20, 2024)
TG0 | $5,619,170 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Certified by Founder
Lodge
Ochre Bio
start up
United Kingdom
- Oxford
- 11/10/2022
- Series A
- $30,000,000
Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally.
Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub. To learn more, please visit www.ochre-bio.com.
- Industry Biotechnology Research
- Website https://www.ochre-bio.com/
- LinkedIn https://www.linkedin.com/company/ochre-bio/
Related People
Jack O'MearaCo Founder
United Kingdom -
Oxford, England,
I help to get new medicines and healthcare technologies to patients.
Interested in the intersection of science, medicine, and business.
ŌURA | $200,000,000 | (Dec 20, 2024)
Buildpeer | $2,500,000 | (Dec 20, 2024)
Embeddable | $6,238,050 | (Dec 20, 2024)
Tenor | $5,400,000 | (Dec 20, 2024)
SOTELIX Endoscopy | $1,700,000 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
TripSuite | $5,000,000 | (Dec 20, 2024)
Seekho | $8,000,000 | (Dec 19, 2024)